4'-O-Methyltransferase Enzymatic Production of Cinnamic Acid Amides

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current biotechnological processes for producing methylated cinnamic acids and phenethylamines, such as rubemamine, are inefficient and not suitable for industrial-scale production, with low yields and lack of reproducibility.

Innovation Solution

Development of fermentative and enzymatic biotechnological processes using recombinant microorganisms and fungi expressing specific enzymes like 4'-O-methyltransferase, 4-coumarate:CoA ligase, and tyramine-N-hydroxycinnamoyltransferase, along with S-adenosylmethionine synthase, to produce methylated cinnamic acids, esters, and amides, including rubemamine, on an industrial scale.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional biotechnological processes are used for producing methylated cinnamic acids and phenethylamines, then production can occur, but yields are low and processes are not suitable for industrial-scale production

Engineering Contradiction:
ImproveyieldVSAvoidindustrial suitability
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent divides the biosynthetic pathway into distinct enzymatic steps, each catalyzed by a specific enzyme (4-OMT for 4'-O-methylation, 3-OMT for 3'-O-methylation, SAMS for SAM synthesis). This segmentation allows for optimized expression of individual enzymes in recombinant microorganisms, improving overall pathway efficiency and industrial scalability while achieving high yields of methylated cinnamic acids and phenethylamines.

Inventive Principle:
Principle #1Segmentation

2Manufacturing precision

If existing O-methyltransferases are used, then 3'-position methylation occurs, but 4'-position methylation is not achieved

Engineering Contradiction:
Improveposition selectivityVSAvoidsubstrate specificity
Core Design Contradiction:
Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The patent introduces a 4'-O-methyltransferase (4-OMT) with specifically engineered or selected catalytic properties that target the 4'-position of cinnamic acid derivatives. This enzyme has localized activity at the 4'-hydroxyl group, distinct from conventional 3-OMTs that act at the 3'-position. The 4-OMT may possess specific amino acid substitutions or structural features that confer this positional selectivity, enabling precise control over methylation location for producing desired flavor compounds.

Inventive Principle:
Principle #3Local quality

3Productivity

If multiple enzymatic steps are integrated in recombinant organisms, then production efficiency improves, but process complexity increases

Engineering Contradiction:
Improveproduction efficiencyVSAvoidprocess complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent combines multiple enzymatic functions (4-OMT, 3-OMT, SAMS) into a single recombinant microorganism host. This merging of biosynthetic capabilities allows the organism to perform sequential transformations of substrates through the entire pathway, from cinnamic acid precursors through methylation steps to final phenethylamine products. The integrated system improves production efficiency by eliminating intermediate purification steps while managing complexity through coordinated gene expression.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The processes enable the reproducible and scalable production of these compounds, improving yield and efficiency by integrating metabolic pathways in recombinant organisms, facilitating the industrial production of desired flavor compounds.

Implementation Method 1

The present invention relates to both fermentative and biotechnological processes for the production of 4'-O-methylated cinnamic acid amides using a 4'-O-methyltransferase

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

The present invention further relates to vector systems and recombinant microorganisms or fungi which can encode/express the enzymes for carrying out the present invention, including S-adenosylmethionine synthase

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

The formation of coenzyme A esters of cinnamic acids through the activity of 4-coumarate:CoA ligases is also known

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 4

the ligation of the formed CoA esters with the amines by tyramine-N-hydroxycinnamoyltransferases

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 5

The 3' position is always modified by 3'-O-methyltransferases (3-OMT)

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentEP3050971B1Process for the enzymatic production of a 4-O-methylated cinnamic acid amide
Publication Date: 2020.06.24 SYMRISE GMBH & CO KG
  • EP3050971B1 patent drawingFigure 1
  • EP3050971B1 patent drawingFigure 2
  • EP3050971B1 patent drawingFigure 3

AI summary

The invention relates to the provision of both fermentative and biotechnological processes for the production of 3,4-methylated cinnamic acids, 3,4-methylated cinnamic acid esters, 3,4-dimethoxyphenethylamine, and 4-methylated cinnamic acid amides using a 4'-O-methyltransferase, optionally in combination with other enzymes, wherein the enzymes were selected by metabolic engineering and optionally adapted by targeted optimization, as well as to compositions obtained by the processes. The invention further relates to vector systems, recombinant microorganisms or fungi, and specific nucleic acid fragments and polypeptides.